| scholarly article | Q13442814 |
| P50 | author | Geert-Jan Boons | Q38318328 |
| Kelley W Moremen | Q56917016 | ||
| P2093 | author name string | Shuo Wang | |
| Lance Wells | |||
| Zoeisha S Chinoy | |||
| David H Live | |||
| Annapoorani Ramiah | |||
| Jeremy L Praissman | |||
| P2860 | cites work | A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases | Q22008686 |
| Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family | Q24290427 | ||
| Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE | Q24301093 | ||
| Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase | Q24312078 | ||
| Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis | Q24314988 | ||
| SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function | Q24316126 | ||
| Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis | Q24631229 | ||
| A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation | Q24672668 | ||
| Mammalian O-mannosylation: unsolved questions of structure/function | Q26860991 | ||
| O-Mannosylation and human disease | Q27014986 | ||
| Structural basis for the substrate specificity of tobacco etch virus protease | Q27639791 | ||
| Enzymatic Basis for N-Glycan Sialylation: STRUCTURE OF RAT 2,6-SIALYLTRANSFERASE (ST6GAL1) REVEALS CONSERVED AND UNIQUE FEATURES FOR GLYCAN SIALYLATION | Q27680447 | ||
| 1H, 13C and 15N chemical shift referencing in biomolecular NMR | Q27860609 | ||
| Hereditary multiple exostoses and heparan sulfate polymerization | Q28213553 | ||
| LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy | Q28512184 | ||
| Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2 | Q28592706 | ||
| Dystroglycan organizes axon guidance cue localization and axonal pathfinding | Q28593913 | ||
| Fer kinase regulates cell migration through α-dystroglycan glycosylation | Q30506035 | ||
| Enhancement of the quality of MALDI mass spectra of highly acidic oligosaccharides by using a nafion-coated probe | Q30655272 | ||
| Cloning, expression, purification, and characterization of the acid alpha-mannosidase from Trypanosoma cruzi | Q31951254 | ||
| Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. | Q34042753 | ||
| O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. | Q34090655 | ||
| Glycoproteomic characterization of recombinant mouse α-dystroglycan | Q34126184 | ||
| Why are glycoproteins modified by poly-N-acetyllactosamine glyco-conjugates? | Q34175480 | ||
| Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. | Q34223029 | ||
| Engineering and characterization of a superfolder green fluorescent protein | Q34478574 | ||
| Glycomic analyses of mouse models of congenital muscular dystrophy | Q35065134 | ||
| A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. | Q36232550 | ||
| NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation | Q36249961 | ||
| Dystroglycan: from biosynthesis to pathogenesis of human disease. | Q36367346 | ||
| Comprehensive enzymatic characterization of glycosyltransferases with a beta3GT or beta4GT motif | Q36657262 | ||
| The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy | Q36666131 | ||
| Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. | Q36731388 | ||
| Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond | Q36855538 | ||
| Expression and function of the HNK-1 carbohydrate. | Q37007210 | ||
| Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. | Q37160880 | ||
| Association of beta-1,3-N-acetylglucosaminyltransferase 1 and beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis | Q37193509 | ||
| Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion | Q37421256 | ||
| Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins | Q37421355 | ||
| Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry | Q37572562 | ||
| Vertebrate protein glycosylation: diversity, synthesis and function | Q37601831 | ||
| Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy | Q37609175 | ||
| Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis | Q37624230 | ||
| Protein O-mannosylation in metazoan organisms | Q37698536 | ||
| Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells | Q37869710 | ||
| Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies | Q37913913 | ||
| The ever-expanding spectrum of congenital muscular dystrophies | Q38029277 | ||
| Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates | Q38208557 | ||
| Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells | Q39034783 | ||
| B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma | Q39080654 | ||
| Poly-N-acetyllactosamine extension in N-glycans and core 2- and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1,4-galactosyltransferase gene family | Q41728101 | ||
| O-glycosylation of the non-canonical T-cadherin from rabbit skeletal muscle by single mannose residues | Q43528757 | ||
| 160 kb deletion in ISPD unmasking a recessive mutation in a patient with Walker-Warburg syndrome | Q46105701 | ||
| A truncating mutation in B3GNT1 causes severe Walker-Warburg syndrome | Q47956367 | ||
| O-mannosylation in mammalian cells | Q48384315 | ||
| Impaired sexual behavior in male mice deficient for the beta1-3 N-acetylglucosaminyltransferase-I gene. | Q51727809 | ||
| ??? | Q22009535 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | poly-N-acetyllactosamine biosynthetic process | Q21108245 |
| Beta-1,4-glucuronyltransferase 1 | Q21108246 | ||
| UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Q21109547 | ||
| LARGE xylosyl- and glucuronyltransferase 1 | Q21117620 | ||
| glycosylation | Q898365 | ||
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | eLife | Q2000008 |
| P1476 | title | B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan | |
| P478 | volume | 3 |
| Q42506388 | 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy. |
| Q90362813 | A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan |
| Q57458034 | A two-phase model for the non-processive biosynthesis of homogalacturonan polysaccharides by the GAUT1:GAUT7 complex |
| Q89047205 | CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of α-dystroglycan |
| Q37709546 | Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women - a multivariate explorative cross-sectional study |
| Q92711724 | Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy |
| Q41642554 | Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx |
| Q35709549 | Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy. |
| Q47281956 | Expression system for structural and functional studies of human glycosylation enzymes |
| Q36960788 | Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy |
| Q90154126 | HNK-1 Sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan |
| Q36919737 | ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan |
| Q37472546 | LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans. |
| Q90362150 | Laminin G-like domains: dystroglycan-specific lectins |
| Q64233103 | Mammalian O-mannosyl glycans: Biochemistry and glycopathology |
| Q38424785 | Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. |
| Q36738591 | Milder forms of muscular dystrophy associated with POMGNT2 mutations |
| Q47168266 | Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy |
| Q35451121 | Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain |
| Q55440689 | Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice. |
| Q46448834 | Protein O-Linked Mannose β-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of α-Dystroglycan |
| Q50325365 | Rapid screening of sugar-nucleotide donor specificities of putative glycosyltransferases. |
| Q40092479 | Recent advancements in understanding mammalian O-mannosylation |
| Q90438803 | Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth |
| Q34469573 | Secretome analysis identifies novel signal Peptide peptidase-like 3 (Sppl3) substrates and reveals a role of Sppl3 in multiple Golgi glycosylation pathways |
| Q112700782 | Small RNAs are modified with N-glycans and displayed on the surface of living cells |
| Q32884430 | The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan |
| Q28546951 | The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy |
| Q41820882 | The evolution of the dystroglycan complex, a major mediator of muscle integrity |
| Q32884479 | The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition |
| Q28085305 | The secretory pathway kinases |
| Q38796983 | What Have We Learned from Glycosyltransferase Knockouts in Mice? |
Search more.